InvestorsHub Logo
Followers 193
Posts 16600
Boards Moderated 10
Alias Born 01/29/2018

Re: stervc post# 21928

Monday, 09/07/2020 11:07:52 AM

Monday, September 07, 2020 11:07:52 AM

Post# of 63384
That's the thing about resumes, they're always "dressed up." He'd been separated from that first company, Caldrius, before they acquired the stem cell company that led to their growth onto the NASDAQ.

https://www.sec.gov/Archives/edgar/data/320017/000114420411020360/v216923_10k.htm

Before that, it was a typical OTC company, and then an ASE company, very thinly traded because nobody was interested in the stock.

And working for "big companies" doesn't make one a big deal.

He's been the CEO of this company for, what, a decade?

Use of the presentation material the company put together for its last failed attempt to get funding for its trial is typical for an OTC "valuation." Of course the company is going to put on the dog and pony and say that it's great, its tech is great, its people are great, etc., as it grovels for that funding. The problem is nobody bought either a dog or a pony after hearing the sales pitch.

The company is fundamentally worthless and in bankruptcy. If it emerges under this "plan," it won't even be close to meeting any of the listing requirements for NASDAQ.


I swear I’ll never use the phrase “you can’t make this stuff up” ever again after being on the OTC. Apparently you can.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BRTX News